A customer centric approach has always driven the marketing efforts at Emcure. Innovative, high quality products, proximity to the customer, extensive reach through a countrywide distribution network and a dedicated sales team of over   2500 professionals have been the building blocks of Emcure’s consistent sales performance.

Apart from a strong presence in India, where we are ranked amongst the top 20 Indian sales organisations. Emcure has a presence in Asia, Africa, CIS, Latin America, the Middle East and Europe. Our strength lies in critical areas such as new product launches and marketing as well as regulatory skills for quick registrations of new products.

Emcure has entered into a number of co-marketing arrangements with global and Indian manufacturers for in-licensing and out-licensing of products. Emcure is constantly growing its portfolio of in-licensed products and offers a strong domestic infrastructure to partners.

Emcure aims to consolidate its position and emerge as one of the top Indian pharmaceutical marketing companies in the near future.
 

Indian Presence

Emcure’s domestic marketing activity commenced in 1995 and in the short span that has elapsed, we have risen to be ranked amongst the top 20 Indian pharmaceutical companies. The Company has demonstrated strong product management and marketing skills. Rapid product introductions and launching of innovative products such as chiral formulations has fuelled growth in the domestic market. Emcure has a large number of product introductions to its credit and has used innovative marketing strategies to drive growth.

An extensive infrastructure of 5 regional offices, a national distribution network and cold storage facilities gives us the distinct advantage of catering to all corners of the country.

Today, Emcure's brands reach over 100,000 pharmacies and are detailed regularly to doctors through over 200,000 doctor visits every month.

The high powered Medical Advisory Committee chaired by Dr. R.P. Soonawala, India’s eminent gynecologist guides Emcure in its endeavours to add value to the medical practitioner and his patients. The Emcure Medical Advisory Board comprises of luminaries from the medical profession in fields such as Gynecology, Oncology, Cardiology, Otolaryngology, Orthopedics, Nephrology, Pediatrics, HIV/AIDS and Haematology.

Building on inherent manufacturing and marketing strengths, Emcure ventured into Exports in the year 2000 and a separate International Division was formed. The International Division at Emcure is staffed by an experienced set of professionals with hands-on experience in developing new markets. The success of exports from Emcure is evident from the number of products already registered and under registration across the various continents.

Currently Emcure products are available in more than   65 countries across Asia, Africa, CIS, Europe, Latin America and the Middle East. An on-field direct sales presence in key markets helps Emcure generate demand, create markets and stay in touch with the end consumer. Emcure’s Chiral and other innovative molecules and formulations have been licensed to number of business partners globally.

Therapeutic Segments

Emcure operates through 10 marketing teams. Each division is led by a senior Emcurean and a dedicated sales force. Product management is done through independent teams in each of these divisions.

1. Pharma :

Focuses on Gynecologists, Physicians, General Practitioners, Surgeons and Orthopedics.

2. Shweiz :

Focuses on Orthopedics, Gynecologists, Gastroenterologists and General Practitioners.

3. Nucron :

Focuses on Cardiologists, Diabetologists, Physicians and General Practitioners.

4. Global HIV Initiative:

Responsible for Anti-Retroviral business and Corporate Social Responsibility on HIV and AIDS.

5. Gennova Renal Care :

Focuses on Renal Care.

6. Elaxim :

A revolutionary thrombolytic that works in 5 seconds and has thrombolised more than 9000 patients till December 2009.

7. Neurosciences :

This is Emcure’s recent entry focusing on Neurology and Psychiatry.

8. Zuventus :

Focuses on General Practitioners, Physicians, Cardiologist, Gynecologist, Paediatrician, General Surgeon, Orthopedic, Cardiovascular Thoracic Surgeons, Plastic Surgeons, Diabetologist.

9. Gromaxx :

Focuses on Gastroenterologists, ENT, Chest Physicians.

10. Oncocare :

Focuses on Oncology.

Co-marketing opportunities

Building Brands

A number of opportunities exist in marketing of brands in India in the post WTO regime. Emcure is keenly looking to explore in-licensing opportunities and offers a strong domestic infrastructure to partners. Emcure is attractively positioned through its regulatory experience, infrastructure and sales strengths as well as marketing skills to maximize sales for partners through adding your brands to Emcure's existing portfolio or creating new focused sales teams for promoting complementary products and innovator brands into the country.

Emcure’s proprietary pipelines of important chemical entities such as Chiral molecules and other niche products are available for partners to market in countries where they are present. These include Sevelamer Hydrochloride, Ferrous Ascorbate and a range of Chiral molecules.